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ABSTRACT 1 
Vaccination is an important tool in poultry health, but is itself a stressor often resulting in a 2 
reduction in feed intake, body weight gain, and nutrient digestibility. In other species 3 
vaccination is associated with an immediate acute-phase response. As an important immune 4 
parameter, the circulating heterophil/lymphocyte (H/L) ratio is a well-recognized parameter 5 
of stress in poultry. In this study, the effects of a routinely used commercial poultry vaccine 6 
on the acute phase response (APR) and H/L ratios in specific pathogen free (SPF) layer 7 
chicks was examined to determine if post vaccination (PV) stress and an APR occur. A 8 
combined Newcastle disease and Infectious bronchitis vaccine (Nobalis Ma5+Clone 30) was 9 
administered to SPF chicks by the intraocular route at age 7 days. Acute phase proteins 10 
(APP), alpha-1 acid glycoprotein (AGP) and serum amyloid A (SAA) were measured by 11 
enzyme-linked immunosorbent assays at 0 (pre-vaccination) and 0.5, 1, 2, 3, 4, 5, 6 and 21 12 
days, PV. Stress was determined in the chicks by measurement of the H/L ratio. The immune 13 
response to the vaccine was estimated by measurement of the antibody (IgY) response to the 14 
vaccine at day 21.  15 
The antibody titer was significantly (P < 0.05) higher in the vaccinated group at 21 days PV 16 
confirming stimulation of the immune system. The H/L ratio was also significantly higher in 17 
the vaccinated group at 1-2 days (P<0.01) and at 3 days (P<0.05) PV. The concentration of 18 
SAA increased by 2.8-fold, from 63.7 µg/ml in controls to 181 µg/ml in the vaccinated 19 
group, (P<0.05) at 1 day PV. AGP increased 1.6-fold at 2 days PV, (from 0.75 g/ml in the 20 
control group to 1.24 g/ml in the vaccinated group, P<0.05).   21 
In conclusion an immediate but mild APR occurred in the chicks following intraocular 22 
vaccination, whereas the stress response as measured by H/L ratio seemed to be more specific 23 
and sensitive.  Measurement of these biomarkers of the host response could be a tool in 24 
vaccine development. 25 
ACUTE PHASE PROTEINS AND STRESS IN RESPONSE TO VACCINE 
 
 
2 
 
 
INTRODUCTION 
Acute phase proteins (APP) are a group of blood proteins involved in restoring homeostatic 26 
balance by restricting growth of microorganisms, mediating the inflammatory response and the 27 
effects of stress through an antibody-independent response. The APP are also considered to 28 
have diagnostic and prognostic potential because of the correlation between their concentration 29 
in blood and the response of the host to infection or inflammation (Cray, et al., 2009). There is 30 
increasing interest in APPs in chickens as a physiological marker for health and welfare 31 
including infection and intriguing vaccine response to both bacterial and viral pathogens 32 
(O'Reilly and Eckersall, 2014). Responses of APP in terms of vaccination stimuli have been 33 
investigated in other species, for instance, in horses (Andersen, et al., 2012) in sheep (Eckersall, 34 
et al., 2008) and in calves (Arthington, et al., 2013). These previous studies reported an acute 35 
phase response to a variety of vaccines and therefore suggest the possibility that monitoring 36 
the APP may be a means to determine the efficacy of a vaccine in stimulating the innate 37 
immune system and as such could be a tool of value in vaccine development.   38 
In chickens, alpha-1 acid glycoprotein (AGP) responds as a moderate positive APP (Chamanza, 39 
et al., 1999; O'Reilly and Eckersall, 2014) following experimental infection.  Investigation of 40 
the plasma AGP response, in White Leghorn SPF chickens at age 3 weeks old, inoculated by 41 
an intraocular route with a highly virulent strain of Gumboro disease virus, showed an increase 42 
in serum AGP concentration of 4.6-fold at 2-day post immunization which peaked at 6 days at 43 
6.2-fold the pre-treatment level. In contrast, inoculation with an attenuated strain of Gumboro 44 
disease virus lead to a peak in AGP of 2.4-fold at day 2 post inoculation (Inoue, et al., 1997). 45 
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AGP levels have also been shown to increase significantly (P<0.05), at 12-48 h post IV 46 
injection with lipopolysaccharide (LPS) from Escherichia coli (E. coli) in male broiler chickens 47 
at 3 weeks old (Takahashi, et al., 1998) 48 
Inoculation of commercial layer chickens with Mycoplasma gallisepticum vaccine caused a 49 
significant increase in serum AGP concentration, which started at 1 day PV(Peebles, et al., 50 
2014). In this study the vaccine was administered via the intraocular route in one group and 51 
subcutaneous injection in another group. The concentration of AGP remained significantly 52 
higher, in both administration routes, than in the control group for up to 21d post inoculation.   53 
Serum amyloid A (SAA) is another major positive APP in chickens (Alasonyalilar, et al., 2006) 54 
and is immunomodulatory, inhibiting pyrexia and down regulating pro-inflammatory events 55 
during an APR (Shainkinkestenbaum, et al., 1991; Uhlar and Whitehead, 1999). However due 56 
to the lack of commercial assay systems there have been few reports on this APP in chickens 57 
and none in relation to post vaccination stimulation.  In this study we were able to monitor 58 
SAA in chicken serum using a newly available species specific ELISA system and therefore 59 
determine if this major APP is also stimulated by vaccination.  60 
Changes in white blood cell count, especially in Heterophils/Lymphocyte (H/L) ratio have been 61 
used as a measure of stress in chickens (Gross and Siegel, 1983; Shini, et al., 2008) (Crowther, 62 
2009; Ohara, et al., 2015). The H/L ratio of birds can be affected by health disturbance or stress 63 
(Crowther, 2009), including transport stress (Huff, et al., 2005; Matur, et al., 2016) possibly 64 
due to the transition of leukocytes from the marginal pool to peripheral circulation (Duncan JR, 65 
1987).  66 
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In this study we measured the AGP, SAA and the H/L ratio in specific pathogen free (SPF) 67 
chickens following routine vaccination via the intra-ocular route to determine whether the 68 
immediate post-vaccination innate immune or stress response was most sensitive to the mild 69 
or severe vaccination stress. Our specific aim was to determine if an immediate APP response 70 
occurs following intra-ocular vaccination as well as via the intra muscular route (Peebles, et 71 
al., 2014) which would allow subsequent investigations on the pathophysiology of avian 72 
APPs and their interaction with the protection of the host provided by such vaccination.  The 73 
vaccine chosen for the study, a combined Newcastle disease and Infectious Bronchitis (N/B) 74 
Live, freeze-dried virus vaccine, is routinely used in chicken production and this dual vaccine 75 
was selected to stimulate an APP response under conditions similar to those on commercial 76 
farms. Vaccination routes recommended for this vaccine are by spray, in drinking water or by 77 
eye drop. Intraocular vaccination (eye drop) was selected to ensure every individual bird 78 
received the same dose, which could not be guaranteed with the other routes. To evaluate the 79 
success of the vaccine, the amount of specific antibody (IgY) raised against the immunogen 80 
proteins of the vaccine after 21 days, was also determined. 81 
MATERIAL AND METHODS 82 
SPF Chicks and Housing  83 
One hundred and eighty 1-Day old SPF White leghorn layer chicks were hatched out at the 84 
experimental farm (Cochno Research Farm, University of Glasgow) and divided into two 85 
batches each containing 90 chicks.  Each batch of chicks was then placed in a separate 86 
controlled environmental room (R1 an R2) in one of two pens (n=45 per pen). The two pens in 87 
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each room had a litter of wood shavings and were fitted with a brooding ring. The stocking 88 
density was 12chicks/m2. 89 
The chicks were fed ad libitum with a commercially available chick crumb formulated to meet 90 
or exceed National Research Council (NRC, 1994) guidelines and the birds had access to fresh 91 
water throughout the study period.  The light, temperature and ventilation within each room 92 
were automatically controlled and adjusted according to management guide recommendations.  93 
The chicks were allowed to adjust to their environment for the first 7 days before the 94 
experiment commenced. Strict biosecurity was applied to prevent cross contamination between 95 
the two rooms and each pen, not least the controls (R2) were always visited first and then the 96 
vaccinated room (R1). 97 
Experimental Design  98 
The experiment commenced when the chicks were 7 days old. There were 9  sampling time 99 
points; pre (0) and post vaccination (PV) at 12h, 24h, and then 2, 3, 4, 5, 6, and 21 day thereafter. 100 
At each time point 12 chicks were weighed and culled and samples collected, 6 per treatment 101 
and 3 per replicate pen.  Full ethics approval was granted in advance by the University of 102 
Glasgow MVLS College Ethics Committee.  103 
Vaccine and Vaccination 104 
A commercially available combined Newcastle disease and Infectious Bronchitis (N/B) Live, 105 
freeze-dried virus vaccine (Nobalis Ma5+Clone 30, MSD Animal Health) was used in this 106 
experiment. After re-constituting the vaccine in sterile saline solution, each dose contained at 107 
least 103.5 EID50 of the IB strain Ma5 and 10
6 EID50 Newcastle disease virus strain Clone 30.  108 
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The chicks in pens 1 and 2 in R1 were weighed and the vaccine was administered by the intra-109 
ocular route with one drop applied to one eye. A sterile saline solution was administered by the 110 
same route to control animals in pens 1 and 2 which were housed in R2. 111 
 112 
Blood Sampling and Assessment 113 
At each sampling time point three chicks were chosen from each replicate pen, weighed then 114 
humanely culled by dislocation of the neck followed by decapitation. Following decapitation, 115 
approximately 1.5 ml of blood was collected from the major vessels in the neck using 116 
heparinized tubes. Fresh blood was used to make blood smears to determine the H/L ratio; the 117 
remainder was centrifuged (3000 × g) for 15 min at 4 ◦C and the plasma immediately frozen at 118 
-20◦C . SAA and AGP levels were measured in all samples collected using commercially 119 
available ELISA kits described below. Plasma from samples on day 0 and 21 days were used 120 
to estimate the antibody titers as detailed below.  121 
Heterophil / Lymphocyte Ratios:   122 
Differential WBC counts were carried out on the blood smears stained with the May-123 
Grunwald-Giemsa stain. Two hundred leucocytes were counted and classified per slide. The 124 
H/L ratio was calculated by dividing the total number of Heterophils by the total number of 125 
Lymphocytes (Gross and Siegel, 1983; Ohara, Oyakawa, Yoshihara, Ninomiya and Sato, 126 
2015). Samples used for this technique were at 0, 1, 2, 3, 4, 5, 6 day post vaccination and we 127 
dropped 12h post vaccination for technical issues. 128 
Antibody Titer Raised Against the Vaccine:  129 
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A modified antibody (Ab) titration assay (Crowther, 2009; Snyder, et al., 1983) was used to 130 
determine the amount of IgY Ab raised against the vaccine in this study. A 96 well plate (Costar 131 
Assay Plate, CORNING) was coated with the Newcastle and Infectious Bronchitis vaccine 132 
(Nobalis Ma5+Clone 30) diluted to a protein concentration of 20µg/ml in 0.2M carbonate 133 
bicarbonate buffer at pH 9.5 and incubated at 4oC overnight.  The protein content of the vaccine 134 
had been determined by a Bradford protein assay (Sigma Chem Co. Poole, UK) with bovine 135 
serum albumin as the standard.  Each well was then aspirated and washed 4 times using Tris-136 
buffer saline (TBS) 50 mM Tris-Cl, pH 7.5 containing 0.05% tween-20. Wells were blocked 137 
with 200µl of 5% (w/v) Marvel milk protein diluted in TBS-T (0.05%) over an hour at room 138 
temperature on a rocking plate. The plate was then washed as above.   139 
Antibody standards were made by serially diluting pooled samples collected from vaccinated 140 
birds sampled at 21day post vaccination and by diluting 1:20 in TBS-T with 0.5% Marvel milk. 141 
This was standard 1 (S1) and given a value of 100 arbitrary units (AU) of antibody.  It was then 142 
diluted in a 6-fold serial dilution to S6 (3.13 AU) using TBS-T with 0.5% Marvel milk.  The 143 
chicken serum samples also were diluted 1:80 in TBS-T 0.5% Marvel milk. To duplicate wells 144 
a 100 µl aliquot of diluted standard or sample was added. After 1 hour incubation with constant 145 
shaking at room temperature, the plate was washed as above.  The second antibody, anti-146 
Chicken IgY VHH Single Domain Antibody conjugated to horse radish peroxidase (HRP) 147 
(Abcam, Cambridge, UK), was diluted to a concentration of 1:5000 with TBS-T 0.5% Marvel 148 
milk and added before incubating for another 1 hour at room temperature by constant shaking 149 
then washed as above. 100μl of tetra-methylbenzidine (TMB, KPL laboratories, Inc., Maryland, 150 
USA) was then added to each well for 20 minutes at room temperature whilst rocking until a 151 
blue color developed, then 100μl of stop solution (2M H2SO4) was added.  This caused the 152 
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color to change to yellow. The absorbance of the resulting solution was measured at 450nm 153 
using an OPTIMA absorbance microplate reader (BMG Labtech Ltd, Bucks, UK). A standard 154 
curve using 4-parametre fit curve was used to determine the antibody response.  155 
Enzyme Linked Immunosorbent Assays (ELISA) 156 
The ELISA assays for chicken APPs were obtained from Life Diagnostics Inc, (West Chester, 157 
USA). They were performed according to the manufacturer’s instructions with a dilution factor 158 
for the serum samples of 1:10000 for AGP and 1:20 for SAA. Each individual sample was run 159 
in duplicate. 160 
ELISA Assay for AGP: Diluted samples and standards were mixed thoroughly and 100μl of 161 
each sample or standard was dispensed into duplicate wells of 96-well microtiter plate. This 162 
was then incubated on an orbital microplate shaker at 150 revolutions per minute (rpm) at room 163 
temperature (RT) for 45 min. Contents of the wells were then discarded and the wells were 164 
washed five times each using 1x wash buffer. After ensuring all residual droplets in the wells 165 
were removed by striking plates onto absorbent paper, 100μl of the secondary antibody-HRP 166 
conjugate was then dispensed into each well and incubated on the shaker at RT for 45 min. The 167 
wash step was repeated and 100μl of TMB reagent (HRP substrate) was dispensed into wells 168 
and a blue color development was allowed to proceed for 20 min on the shaker at RT. The 169 
reaction was stopped by adding 100μl of stop solution per well into the wells. Absorbance was 170 
read using a FLUOstar Optima plate reader at 450 nm within 15 min of stopping the reaction. 171 
A four-parameter logistic curve (4PL) was used as described above.  Intra assay coefficients of 172 
variance (CVs) were 4.7% at 76.2g/L ± 3.6 (mean ± SD) and 3.7%, at 32.6g/L ± 1.48 (mean ± 173 
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SD) (n= 40). Inter assay CVs were 2.7%, at 43.6g/L ± 1.17 (mean ± SD) and 5.8%, at 70.8g/L 174 
± 6.4 (mean ± SD) (n= 5) and the limit of detection was 1.7g/L (3 SD from zero sample) 175 
ELISA Assay for SAA: Serum samples (50μl) were first incubated in a heat block at 60oC for 176 
one hour to dissociate SAA from lipoproteins. Following heat treatment, the diluted samples 177 
and standard (100µl) were incubated in the antibody-coated microtiter wells in duplicate 178 
together with HRP conjugate (100µl) for one hour. As a result, SAA molecules become 179 
sandwiched between the immobilization and detection antibodies. Contents of the wells were 180 
then discarded and wells washed five times each using 1x wash buffer. After ensuring all 181 
residual droplets in the wells were removed by striking plates onto absorbent paper, 100μl of 182 
TMB Reagent was added and incubated for 20 minutes. Color development was stopped by 183 
the addition of 100μl Stop Solution, changing the color from blue to yellow and the optical 184 
density was measured at 450 nm. A four-parameter logistic curve (4PL) was used as described 185 
above. Intra assay CVs were 5.7 % at   57.5µg/L 4.8 (mean ± SD) and 3.07 % at 25.9μg/L ± 186 
1.8 (mean ± SD) (n= 40), inter assay CVs were 7.6% at 10.5µg/L ± 0.6 (mean ± SD) and 5.3 % 187 
at 103.7µg/L ± 6.2 (mean ± SD) (n= 5) and the limit of detection was 0.21 µg/L (3 SD from 188 
zero sample)   189 
Data Handling and Statistical Analysis 190 
The antibody response to the vaccine, H/L ratios, and acute phase proteins (SAA, AGP) of the 191 
vaccinated and control groups, were compared at each sampling time point using a Mann-192 
Whitney Test for non-parametric distribution (Minitab 17.1.0). In all analyses, P＜0.05 was 193 
used to represent statistical significance. 194 
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RESULTS 195 
 Chick Weights:  196 
The chicks in each group were within the same range, 69.85g (56.5-84.2) median (range) for 197 
the control group and for the vaccinated group 76.4g (60.8-81.2) median (range) at 7 day old. 198 
There were no significant differences in body weight between the groups in response to the 199 
vaccination (Table 1). 200 
 201 
Antibody Titer Raised Against the Vaccine:  202 
The antibody titer was significantly elevated by 3.1-fold (P<0.01) after 21 days to be 488AU 203 
(346-781) median (range) in the vaccinated group compared to the control group 154 AU 204 
(130-186) median (range) (Figure 1).  205 
The Heterophil/Lymphocyte Ratio:  206 
 207 
The H/L ratio increased significantly (P<0.01) to reach a peak of 0.58 (0.39-0.65) median 208 
(range) in the vaccinated group (V) compared to the control group (C) 0.20 (0.08-0.32) median 209 
(range) by on day-1 post treatment (Figure 2). This increase remained significant on day 2 210 
(P<0.01) and day 3 (P<0.05) post treatment. From day-4 there was no significant difference in 211 
the H/L ratio between the control and vaccinated groups.  212 
Acute Phase Proteins 213 
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Alpha-1 Acid Glycoprotein (AGP) in the vaccinated group was statistically different from the 214 
AGP levels in the control group on day-2 post treatment. AGP increased 2-fold from 0.47g/L 215 
(0.22-0.49) median (range) in the control group to1.007g/L (0.45-1.39) median (range) in the 216 
vaccinated group, P< 0.05 (Figure 3). At day-3 post treatment the AGP levels were not 217 
statistically different from the control animals. At day -6 post treatment, another significant 218 
increase (P< 0.05) in the levels of AGP in the vaccinated group over controls was observed 219 
with a 1.9-fold increase from 0.54g/L (0.37-0.68) median (range) in the control group to 220 
0.99g/L (0.53-1.29) median (range) in the vaccinated group.  221 
Serum Amyloid- A (SAA) levels were significantly higher in the vaccinated group on  day-1 222 
post treatment  (P< 0.05) with a 2.5-fold  increase from 39.5µg/L (20.6-63.7) median (range), 223 
in the control group to 103.5µg/L (61-180.9) median (range), in the vaccinated group. 224 
Thereafter there was no significant difference except on day-6 post vaccination when the 225 
SAA concentration was significantly higher in the vaccination group with a 2.8-fold (P<0.01) 226 
increase from 42.5µg/L (22.7-63.3) median (range) in the control group to 105.5µg/L (63.8-227 
238.1) median (range) in the vaccinated group (Figure 4).  228 
 229 
DISCUSSION 230 
This investigation showed that an intra-ocular vaccination of SPF layer chicks with a dual 231 
vaccine against Newcastle disease virus and infectious bronchitis causes an immediate but mild 232 
APP response with small increases in AGP and SAA on day 2 and day 1 post vaccination 233 
respectively.  We also demonstrated that the vaccinated birds underwent a mild vaccination 234 
stress response with H/L ratios remaining higher in the vaccinated birds for up to 3 days post 235 
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vaccination. The efficacy of the vaccine to produce antibody to the immunogens contained, 236 
was confirmed by demonstration of the presence of specific antibody on day 21 post 237 
vaccination. 238 
The SAA concentration in many species is related to the severity or virulence of the 239 
pathogen, and it can be used as marker for detection of inflammation (Ceron, et al., 2005; 240 
Eckersall, 1995) serving as an indicator of the immediate innate immune response to 241 
stimulations such as by vaccination. SAA usually increases within several hours (5-6 hours in 242 
humans) of an inflammatory event and decreases after 48 hours and typically increases 10 243 
to100-fold during a response (Gruys, et al., 2005; Kushner and Rzewnicki, 1994). In the 244 
current study, the intraocular administration of N/B vaccine stimulated only a mild increase 245 
in the SAA concentration. Though, the serum SAA increased significantly at 24h post 246 
treatment, with a 2.4-fold elevation, same as seen with vaccination in other species. For 247 
instance, SAA levels increased sharply from 5 h to hit the peak at 24 h to be 3.6-fold higher 248 
than the previous level before inoculation following intratracheal inoculation of beef calves 249 
with inactivated Pasteurella multocida, (Dowling, et al., 2004). In lambs, subcutaneous 250 
vaccination with Heptavac P (companied Clostridia and Pastural vaccine) also caused a 251 
significant increase (P<0.01) in both SAA and haptoglobin (Hp). The level of SAA peaked at 252 
24 h reaching a 400-fold increase and did not return to normal concentration until 4 day 253 
(Eckersall, et al., 2008). 254 
In the current study, we observed a second elevation of SAA in the vaccinated group 255 
compared to the control group on day 6 post treatment, which also coincided with a second 256 
peak in AGP concentration. A limitation of our study was that we were not able to repeat 257 
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sample the same individual chicks and so it is not possible to determine if this second peak in 258 
APP was present because some individuals responded more slowly to the vaccination or if 259 
some other factor was coming into play e.g social stress.  The most likely explanation is that 260 
the second APP peak was due to individual differences in the APP response (Elsasser, et al., 261 
2005; Verschuur, et al., 2004). 262 
In the current study AGP in the vaccinated group was significantly higher by a 2-fold increase 263 
at 2-day post treatment. This result is similar to that reported by Sylte and Suarez (2012) who 264 
reported an AGP peak serum concentration of 2.6 -fold at 48h post-experimental infection with 265 
influenza virus in 4wk old White Leghorn chickens. However, we did not see a prolonged 266 
increase in AGP unlike the 96h increase reported by these authors.  Notably the intraocular 267 
inoculation with a vaccine strain of Gumboro disease virus lead to a 2.4-fold increase in plasma 268 
AGP at day 4 post treatment in 3wk old white leghorn SPF chickens (Inoue, et al., 1997) 269 
whereas intraocular inoculation with a highly virulent strain of Gumboro disease virus lead to 270 
an increase of plasma AGP at day 2 which peaked at day 6 post treatment (6.2-fold increase). 271 
Measuring the H/L ratio has been established as means of evaluating stress in chickens 272 
(Maxwell, et al., 1992; McFarlane and Curtis, 1989; Post, et al., 2003; Puvadolpirod and 273 
Thaxton, 2000). In the current study, we observed an increase in Heterophils and a decrease in 274 
Lymphocytes in the vaccinated group, whereas the control animals did not show any significant 275 
change in their H/L ratios. The changes we observed in the H/L ratios was therefore likely to 276 
be related to the vaccine action and its effects on the innate immune response. These 277 
inflammatory mediators also initiate and modulate the APR, which by diffusing into the 278 
extracellular fluid and circulating in the blood, leads to the activation of the hypothalamic-279 
ACUTE PHASE PROTEINS AND STRESS IN RESPONSE TO VACCINE 
 
 
14 
 
pituitary-adrenal axis, decrease production of growth hormone and physiological changes as 280 
fever, lack of apatite and catabolism of muscle cells (Gruys et al., 2005). As a result, 281 
inflammation may have a combined effect on the H/L ratio by increasing Heterophil 282 
concentrations due to increased granulocytopoiesis and decreasing lymphocyte concentration 283 
due to cytokine-mediated increases in corticosterone concentration (Clark, 2015). Change of 284 
the H/L ratio has been reported in birds to be between 0.19 - 64.67 in different diseases (Clark, 285 
2015) so for our vaccinated birds a change in H/L from 0.11 to 0.54 is suggestive of a mild 286 
stress response.  287 
Taken together, the vaccination procedure used in this study caused only a mild APR with only 288 
small increases in AGP and SAA, and a mild change in H/L ratios. This contrasts with results 289 
of post vaccination acute phase reactions in other species and with other types of vaccine.  In 290 
previous reports, the use of an adjuvant may have aided and enhanced the APR e.g. in rabbit 291 
(Destexhe, et al., 2013) and sheep (Eckersall, et al., 2008). Thus, the absence of an adjuvant in 292 
the current N/B vaccine and administration by the intra-ocular route may have led to a moderate 293 
stimulation of the acute phase and stress responses.    294 
In conclusion vaccination of chicks with N/B vaccine by the intra-ocular route produced a mild 295 
acute phase response and vaccination stress response in 7 day old SPF layer chicks. Of the two 296 
methods, the H/L ratio was more sensitive and consistent in terms of measuring the mild 297 
vaccination stress response under the conditions employed in this experiment. Whilst the SAA 298 
and AGP levels increased within 1 and 2 days post vaccination respectfully a limitation of the 299 
design of this experiment was that individual differences in the APR response could not be 300 
taken into account. For future work, it will be of interest to monitor the APR in the same 301 
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individuals using different vaccines and routes of administration and to assess whether the post 302 
vaccine APPs response is correlated to both the H/L ratio and the subsequent antibody Titer.  303 
In addition, characterising post vaccination responses in chickens could be a way of assessing 304 
the dynamic APR and evaluating its potential as a biomarker for disease resistance. 305 
 306 
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Table 1 452 
 453 
Age/ day Sampling time Control 
Median (range) 
Vaccinated 
Median (range) 
P value 
7 0 69.85 (56.5-84.2) 76.4 (60.8-81.2) 0.5752 
8 1 77.55 (68.2-87.6) 78.6 (66.6-99.1) 1.0000 
9 2 85.1 (77.8-97.1) 85.2 (79.4-94.3) 0.7488 
10 3 92.7 (60.5-102.5) 95.45 (80.7-100) 0.0927 
11 4 105.1 (90.4-122.3) 96.3 (58.9-109.6) 0.0929 
12 5 105.35 (93.2-124) 103.5 (90.8-132.1) 0.4712 
13 6 105.05 (95.6-
138.9) 
122.7(91.1-142.7) 0.2980 
28 21 332.95 (294-390.7) 297.1 (271.5-
387.9) 
0.0957 
 454 
Table-1; shows median ±SD of body weight for control and vaccinated groups at each sampling time. There 455 
were no significant differences by Mann-Whitney test, at any sampling time between the groups, N= 6 chicks 456 
per sampling time. 457 
 458 
 459 
 460 
  461 
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Legend to Figures 462 
Figure-1, Antibodies levels pre-treatment 0 and 21 day post treatment in the control (C) (n=6 463 
per time point) and vaccinated (V) groups (n=6 per time point). The difference was significant 464 
P≤ 0.01 at day 21 post treatment. (Horizontal bars with star indicate statistical differences 465 
between groups (** = P≤0.01). Data presented as box and whisker plots with median in the 466 
box, with 25-75 percentile range as the box and the whisker as 10-90 percentiles  467 
 468 
Figure-2:  The Heterophil/Lymphocyte ratio was significantly higher in the vaccinated group 469 
(V) (n=6 per time point) at 1, 2 and 3 days post treatment compared to the control group (C) 470 
(n=6 per time point). (Horizontal bars indicate statistical differences between groups (** = 471 
P≤0.01, * = P≤0.05). Data of 7 sampling time points are presented as box and whisker plots 472 
with median in the box, with 25-75 percentile range as the box and the whisker as 10-90 473 
percentiles. 474 
 475 
Figure-3: Comparison of AGP concentrations in vaccinated (V) (n=6 per time point) and  476 
control groups (C) (n=6 per time point) over the time course of this study. Significant 477 
differences (Horizontal bars) were detected  at day 2 and day 6 post treatment (P< 0.05). Data 478 
of 8 sampling time points are presented in median with 25-75 percentile range as the box and 479 
the whisker as 10-90 percentiles. 480 
 481 
Figure-4:  Comparison of SAA concentration in control (C) (n=6 per time point) and vaccinated 482 
groups (V) (n=6 per time point) over the time course of this study. Significant differences were 483 
detected (Horizontal bars) at day 1 and day 6 post treatment, ** = P≤0.01, * = P≤0.05. Data of 484 
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8 sampling time points are presented as box and whisker plots with median in the box, with 485 
25-75 percentile range as the box and the whisker as 10-90 percentiles. 486 
  487 
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 493 
  494 
ACUTE PHASE PROTEINS AND STRESS IN RESPONSE TO VACCINE 
 
 
24 
 
Figure 2 495 
 496 
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Figure 3 498 
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Figure 4 502 
 503 
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